The recombinant DNA-derived Treponema pallidum membrane protein TmpA, purified from Escherichia coli K-12, was used in an enzyme-linked immunosorbent assay (ELISA) 
The serodiagnosis of syphilis is commonly based on the detection of antibodies against the causative organism, Treponema pallidum, or against cardiolipin (19) .
In Europe, the most frequently used screening test for syphilis is the T. pallidum hemagglutination assay (TPHA; Japan Lyophilization Co.) (5, 7, 15) . A positive TPHA is commonly confirmed by the fluorescent-treponemal-antibody absorption test (FTA-ABS) (19) . Although it is more sensitive than the TPHA, the FTA-ABS is laborious and unsuitable for screening of large numbers of serum samples.
Cardiolipin-based flocculation tests such as the Venereal Disease Research Laboratory (VDRL) test and the Rapid Plasma Reagin card test are also used in screening for syphilis. However, the sensitivities and specificities of such tests have been reported to be less than that of the TPHA (4, 9, 15) . Treatment monitoring is currently done by determination of the decline of anticardiolipin or antitreponemal immunoglobulin M antibodies (5) .
Recently, individual T. pallidum antigens became available as a consequence of the use of recombinant DNA techniques (8, 10-13, 17, 18) . One of the recombinant DNA-derived antigens investigated for use in syphilis serology is the T. pallidum membrane protein TmpA (2) . This 42-kilodalton antigen has been obtained from Escherichia coli K-12 containing plasmid pRIT4661, which could be induced to express high levels of TmpA (L. All sera were stored at -20°C. All sera, except the blood donor sera, were tested by the TPHA, the FTA-ABS (14) , and the VDRL test (14) . The blood donor serum samples were screened by TPHA only.
Purification of TmpA. Isolation and purification of TmpA were performed by the method of Schouls et al. (Schouls et al., submitted), with modifications. E. coli K-12 cells carrying plasmid pRIT4661, which encodes for temperaturedependent hyperexpression of TmpA, were cultured at 28°C for 6 h and subsequently induced to hyperexpression by raising the temperature to 42°C for 1 h. The culture was centrifuged, and the pellet was suspended in 50 mM Tris hydrochloride-5 mM EDTA (pH 8.0). After ultrasonic treatment of the cell suspension, the membrane fraction was solubilized with 1% N-tetradecyl-N,N,-dimethylammonio-1-propanesulfonate (SB 3-14) for 1 h at 37°C. Unsolubilized material was removed by centrifugation at 10,000 x g. The supernatant was purified by DEAE column chromatography using high-pressure liquid chromatography equipment with a TSK 545 column (7.5 x 150 mm; LKB-Producter, Bromma, Sweden). Therefore, the supernatant was diluted five times in TE buffer (0.01 M Tris hydrochloride, 1 mM EDTA [pH 8 .0]). About 10 mg of TmpA in 100 ml of TE buffer containing 0.1% SB 3-14 was loaded into the column. To remove the detergent, the column was washed with 10 ml of a 0.1 to 0% SB 3-14 gradient in TE buffer. Subsequently, TmpA was eluted by 50 ml of a 0 to 0.5 M NaCi gradient in TE buffer at a flow rate of 0.5 ml/min. The fractions containing the TmpA were subjected to preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After electrophoresis, the TmpA-containing polyacrylamide was cut out and TmpA was extracted from the gel by electroelution. TmpA was tested for stability by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and for equal reactivity in the TmpA ELISA during 10 decrease of anti-TmpA antibodies in more detail. The sera of 27 syphilis patients from whom serum samples had been collected before treatment and at various intervals after treatment were compared in the TmpA ELISA, AF-ELISA, and the VDRL test (Table 3 ). The VDRL test titers of all except two sera dropped at least two steps or became nonreactive within 9 months. The results show that the level of anti-TmpA antibodies in the majority of the individuals dropped sharply within a period of 9 months after treatment.
Furthermore, a close resemblance between the drop in OD values obtained by TmpA ELISA and that of VDRL titers was observed. To illustrate this resemblance, the OD values of serum samples from 27 individuals in different stages of syphilis are represented graphically in Fig. 1 . In the majority of the cases studied, the anti-AF antibody levels also dropped after treatment, but the drop was generally less steep than that of the anti-TmpA antibody levels. It should be noted that all sera remained positive in the TPHA and FTA-ABS. The serum samples of only two patients (numbers 17 and 26) showed an OD drop of less than 0.3 and remained highly reactive in the TmpA ELISA. Both were cases of latent syphilis ( 
